Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. products
  3. non muscle invasive bladder cancer
Show results for
Products
Applications

Companies

News

Refine by

Non Muscle Invasive Bladder Cancer Equipment & Supplies

9 equipment items found

Oncodiag Urodiag - Model CE-IVD - Urine-Based Test Kit for Non-Muscle-Invasive Bladder Cancer

Oncodiag Urodiag - Model CE-IVD - Urine-Based Test Kit for Non-Muscle-Invasive Bladder Cancer

Manufactured by:OncoDiag   based inMiserey, FRANCE
An accurate urine-based test for the surveillance of patients with low-, intermediate- and high-risk non-muscle-invasive bladder cancer ...
CONTACT SUPPLIER

UroGen - Model UGN-102 - Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (NMIBC)

UroGen - Model UGN-102 - Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (NMIBC)

Manufactured by:UroGen Pharma, Inc.   based inPrinceton, NEW YORK (USA)
UroGen is developing UGN-102 (mitomycin) for intravesical solution as a primary nonsurgical alternative to repetitive TURBT. UGN-102 is an investigational formulation that utilizes our innovative technology, RTGel™ reverse-thermal hydrogel, for the treatment of low-grade NMIBC. Instilled via standard catheters, UGN-102 is designed to dwell for a period of several hours before being excreted ...
CONTACT SUPPLIER

Protara - Model TARA-002 - Investigational Cell Therapy

Protara - Model TARA-002 - Investigational Cell Therapy

Manufactured by:Protara Therapeutics, Inc.   based inNew York, NEW YORK (USA)
TARA-002 is an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). TARA-002 was developed from the same master cell bank of genetically distinct group A Streptococcus pyogenes as OK-432, a broad immunopotentiator marketed ...
CONTACT SUPPLIER

Theralase - Anti-Cancer Therapy (“ACT”) Technology

Theralase - Anti-Cancer Therapy (“ACT”) Technology

by:Theralase Technologies Inc.   based inToronto, ONTARIO (CANADA)
Theralase is laser focused on advancing the cutting-edge Anti-Cancer Therapy (“ACT”) towards commercialization, providing an alternative treatment methodology for Non-Muscle Invasive Bladder Cancer (“NMIBC”) patients globally. Theralase is dedicated to safely and ...
CONTACT SUPPLIER

Nucleix EpiCheck - Detect Bladder Cancer

Nucleix EpiCheck - Detect Bladder Cancer

Manufactured by:Nucleix Ltd.   based inSan Diego, CALIFORNIA (USA)
Bladder cancer is the 5th most common cancer in the western world, and 70%-80% of the patients are diagnosed with non-muscle invasive disease. There are estimated 400,000 to 800,000 active bladder cancer patients in the United States, as well as 1 to 2 million ...
CONTACT SUPPLIER

Cystoscopy with Blue Light

Cystoscopy with Blue Light

by:Imagin Medical   based inAuburndale, MASSACHUSETTS (USA)
Introduced in 2010, blue light cystoscopy, uses blue-filtered white light to address the limitations of white light cystoscopy. This method involves administering a contrast agent into the bladder which is absorbed by the cancerous cells, causing them to fluoresce when exposed to blue light. Surgeons are then able to view images of the highlighted cancer cells and more effectively identify flat ...
CONTACT SUPPLIER

InnoMedicus - Model COMBAT BRS - Combined Antineoplastic Thermotherapy Bladder Recirculation System

InnoMedicus - Model COMBAT BRS - Combined Antineoplastic Thermotherapy Bladder Recirculation System

Manufactured by:InnoMedicus   based inCham, SWITZERLAND
The Combat BRS System is an innovative bladder recirculation system designed to deliver. Combat BRS is an innovative bladder recirculation system for the treatment of non muscle invasive bladder carcinomas (NMIBC) with thermotherapy and cytostatic agents such as Mitomycin C, Epirubicin, etc. The patented system allows an effective heat exchange with a constant temperature of 43 ±0.5 ...
CONTACT SUPPLIER

MedChemExpress - Model Avelumab - 1537032-82-8

MedChemExpress - Model Avelumab - 1537032-82-8

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated ...
CONTACT SUPPLIER

MedChemExpress - Model Avelumab (anti-PD-L1) - 1537032-82-8

MedChemExpress - Model Avelumab (anti-PD-L1) - 1537032-82-8

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Avelumab (anti-PD-L1) is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Industry Products
  • Medical Industry Software
  • Medical Industry Training
  • Medical Industry Services
  • Medical Industry Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles
  • Medical Industry Books
  • Medical Industry Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT